Shiraz Shabanali Ladiwala bought $253K of Mesa Laboratories (MLAB)
Executed Mar 10, disclosed Mar 10, the same day.
Over the 21 trading sessions from the disclosed entry session (Mar 10), the stock returned +10.8% (delay-adjusted); from the execution session (Mar 10), +10.8%. Derived: entry at the session's open, exit at the close 20 sessions later.
Shiraz Shabanali Ladiwala (Director) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in Mesa Laboratories, Inc. (MLAB). Across 1 priced purchase filing, the average 21-session return was +10.8% from execution and +10.8% from disclosure (delay-adjusted; derived). The largest single filing was $253K of MLAB (3,500 sh × $72.23, as filed), executed Mar 10.
Technology · Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services…
More Technology filings→ Insider filings, newest first→ View the original filing at www.sec.gov→